GSK Seeks Sanctions Against Payors Quitting Avandia MDL
GlaxoSmithKline LLC asked a Pennsylvania federal court on Wednesday to sanction two third-party payors that recently asked to drop their class actions against GSK over the safety of its Avandia diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article